15 May 2023 | Geneva: TDR (the Special Programme for Research and Training in Tropical Diseases) and WHO's Global Tuberculosis Programme announce the availability of an operational research package to evaluate the performance, feasibility, acceptability and impact of treatment decision algorithms for pulmonary tuberculosis (TB) in children.

The International Treatment Preparedness Coalition (ITPC) and the AIDS Vaccine Advocacy Coalition (AVAC) launched a call for applications for the Vaccine Community Advisory Board (Vax CAB).

Over the last year, stakeholders from academia, industry, government, funding agencies, and advocacy groups completed a consensus process on how to include children and adolescents in TB diagnostic development and evaluation.

Among those with MDR-TB included in the meta-analysis, 27% showed resistance to fluoroquinolones and 11% showed resistance to second-line injectable drugs.

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

A Multi-stakeholder hearing on TB was held on 8 May 2023 in order to provide an opportunity for all relevant stakeholders to contribute to the ongoing preparatory process for the upcoming UN High-Level Meeting on TB in September.

BOSTON – New research from Boston Medical Center found that people living with HIV that have had pulmonary tuberculosis had broader and more potent HIV antibody responses and differences in HIV sequences predicted to be antibody resistant as compared to those without suspected or documented tuberculosis. Published in iScience, the study suggests that concomitant tuberculosis disease has a significant impact on HIV immune responses and the viruses circulating in people living with HIV.

Public Health Action is the peer-reviewed open access journal of The International Union Against Tuberculosis and Lung Disease. It communicates and reports new knowledge across all relevant areas of operational research including: infection control, nutrition, TB, HIV, vaccines, smoking, COVID-19, microbial resistance and disease outbreaks.

Primary adrenal insufficiency (PAI) is a common manifestation in patients with adrenal tuberculosis (ATB) and contributes to mortality, according to a study published in the Journal of the Endocrine Society.

A recent systematic review, commissioned by the World Health Organization (WHO), demonstrated that the prevalence of chronic hepatitis C virus (HCV) infection is high among patients with TB. Published evidence on the safety and effectiveness of co-administering treatment for rifampicin-resistant TB and HCV co-infection is extremely scarce and insufficient as a basis to develop global policy recommendations on this intervention.